According to Emergent BioSolutions
's latest financial reports the company has $0.64 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $0.64 B | -53.21% |
2022-12-31 | $1.38 B | -13.89% |
2021-12-31 | $1.61 B | 11.37% |
2020-12-31 | $1.44 B | 32.94% |
2019-12-31 | $1.08 B | 7.68% |
2018-12-31 | $1.01 B | 10.81% |
2017-12-31 | $0.91 B | 53.02% |
2016-12-31 | $0.59 B | -9.67% |
2015-12-31 | $0.66 B | 19.31% |
2014-12-31 | $0.55 B | 13.09% |
2013-12-31 | $0.48 B | 10.64% |
2012-12-31 | $0.44 B | 6.1% |
2011-12-31 | $0.41 B | 11.56% |
2010-12-31 | $0.37 B | 53.21% |
2009-12-31 | $0.24 B | 22.31% |
2008-12-31 | $0.19 B | 16.47% |
2007-12-31 | $0.17 B | 23.61% |
2006-12-31 | $0.13 B | 131.8% |
2005-12-31 | $59.73 M | 160.3% |
2004-12-31 | $22.94 M | |
2002-12-31 | $4.15 M | -112.87% |
2001-12-31 | $-32.3 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $89.28 B | 13,651.42% | ๐บ๐ธ USA |
Merck MRK | $37.63 B | 5,696.24% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $16.28 B | 2,408.55% | ๐ฌ๐ง UK |
Soligenix SNGX | $2.52 M | -99.61% | ๐บ๐ธ USA |
SIGA Technologies SIGA | $0.19 B | -69.68% | ๐บ๐ธ USA |
Celldex Therapeutics CLDX | $0.42 B | -33.90% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $8.12 B | 1,151.50% | ๐ฎ๐ฑ Israel |